Literature DB >> 15708716

Atorvastatin decreases cellular proliferation and bone matrix expression in the hypercholesterolemic mitral valve.

Babu Makkena, Hani Salti, Malayannan Subramaniam, Senthil Thennapan, Robert H Bonow, Frank Caira, Robert O Bonow, Thomas C Spelsberg, Nalini M Rajamannan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15708716      PMCID： PMC3938959          DOI： 10.1016/j.jacc.2004.11.023

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  10 in total

Review 1.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

2.  Association between mitral annular calcium and aortic atheroma as detected by transesophageal echocardiographic study.

Authors:  Y Adler; R Shohat-Zabarski; M Vaturi; Y Shapira; S Ehrlich; R Jortner; A Assali; A Zonshin; A Sagie
Journal:  Am J Cardiol       Date:  1998-03-15       Impact factor: 2.778

3.  The senile cardiac calcification syndrome.

Authors:  W C Roberts
Journal:  Am J Cardiol       Date:  1986-09-01       Impact factor: 2.778

4.  Correlation of serum lipids, calcium and phosphorus, diabetes mellitus, aortic valve stenosis and history of systemic hypertension with presence or absence of mitral anular calcium in persons older than 62 years in a long-term health care facility.

Authors:  W S Aronow; K S Schwartz; M Koenigsberg
Journal:  Am J Cardiol       Date:  1987-02-01       Impact factor: 2.778

5.  Association between mitral annulus calcification and carotid atherosclerotic disease.

Authors:  Y Adler; A Koren; N Fink; D Tanne; R Fusman; A Assali; J Yahav; A Zelikovski; A Sagie
Journal:  Stroke       Date:  1998-09       Impact factor: 7.914

6.  Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve.

Authors:  A Boon; E Cheriex; J Lodder; F Kessels
Journal:  Heart       Date:  1997-11       Impact factor: 5.994

7.  Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve.

Authors:  Nalini M Rajamannan; Malayannan Subramaniam; Margaret Springett; Thomas C Sebo; Marek Niekrasz; Joseph P McConnell; Ravinder J Singh; Neil J Stone; Robert O Bonow; Thomas C Spelsberg
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

8.  Nonobstructive aortic valve calcium as a window to atherosclerosis of the aorta.

Authors:  Y Adler; M Vaturi; I Wiser; Y Shapira; I Herz; D Weisenberg; N Sela; A Battler; A Sagie
Journal:  Am J Cardiol       Date:  2000-07-01       Impact factor: 2.778

9.  Clinical characteristics of patients younger than 60 years with mitral anular calcium: comparison with age- and sex-matched control subjects.

Authors:  C K Nair; C Sudhakaran; W S Aronow; W Thomson; M P Woodruff; M H Sketch
Journal:  Am J Cardiol       Date:  1984-12-01       Impact factor: 2.778

Review 10.  Morphologic features of the normal and abnormal mitral valve.

Authors:  W C Roberts
Journal:  Am J Cardiol       Date:  1983-03-15       Impact factor: 2.778
  10 in total
  8 in total

1.  Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation.

Authors:  Frank C Caira; Stuart R Stock; Thomas G Gleason; Edwin C McGee; Jie Huang; Robert O Bonow; Thomas C Spelsberg; Patrick M McCarthy; Shahbudin H Rahimtoola; Nalini M Rajamannan
Journal:  J Am Coll Cardiol       Date:  2006-03-20       Impact factor: 24.094

2.  Effect of hydroxymethylglutaryl coenzyme-a reductase inhibitors on the long-term progression of rheumatic mitral valve disease.

Authors:  Francesco Antonini-Canterin; Luis M Moura; Roxana Enache; Elisa Leiballi; Daniela Pavan; Rita Piazza; Bogdan A Popescu; Carmen Ginghina; Gian Luigi Nicolosi; Nalini M Rajamannan
Journal:  Circulation       Date:  2010-05-03       Impact factor: 29.690

Review 3.  Reassessment of statins to retard the progression of aortic stenosis.

Authors:  Nalini M Rajamannan
Journal:  Curr Cardiol Rep       Date:  2007-04       Impact factor: 2.931

Review 4.  The role of Lrp5/6 in cardiac valve disease: LDL-density-pressure theory.

Authors:  Nalini M Rajamannan
Journal:  J Cell Biochem       Date:  2011-09       Impact factor: 4.429

5.  Oxidative-mechanical stress signals stem cell niche mediated Lrp5 osteogenesis in eNOS(-/-) null mice.

Authors:  Nalini M Rajamannan
Journal:  J Cell Biochem       Date:  2012-05       Impact factor: 4.429

Review 6.  Myxomatous mitral valve disease bench to bedside: LDL-density-pressure regulates Lrp5.

Authors:  Nalini M Rajamannan
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-03

Review 7.  Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology.

Authors:  Nalini M Rajamannan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-23       Impact factor: 4.733

Review 8.  Medical therapy for rheumatic heart disease: is it time to be proactive rather than reactive?

Authors:  Nalini M Rajamannan; Francesco Antonini-Canterin; Luis Moura; Jose L Zamorano; Raphael A Rosenhek; Patricia Jm Best; Margaret A Lloyd; F Rocha-Goncalves; Sarat Chandra; Ottavio Alfieri; Patrizio Lancellotti; Pilar Tornos; Ragavendra R Baliga; Andrew Wang; Thomas Bashore; S Ramakrishnan; Konstantinos Spargias; Mony Shuvy; Ronen Beeri; Chaim Lotan; Jassim Al Suwaidi; Vinay Bahl; Luc A Pierard; Gerald Maurer; Gian Luigi Nicolosi; Shahbudin H Rahimtoola; K Chopra; Natesa G Pandian
Journal:  Indian Heart J       Date:  2009 Jan-Feb
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.